IVF is recommended for women with complex ovulation disorders, blocked fallopian tubes, low ovarian reserve, severe endometriosis, male infertility, or when other fertility treatments have not been successful.

The success rate for a single IVF cycle is over 45% in women under 35. However, outcomes vary depending on factors such as the woman’s age, how long the couple has been trying to conceive, and the underlying cause of infertility. The cumulative pregnancy rate after three treatment cycles can reach 70–80%.

To increase the chances of success and provide comprehensive support, Inser has developed the Four-Cycle IVF Program.

This program is highly beneficial both physically and emotionally, offering four complete IVF cycles (including fertilization and embryo culture). By increasing the number of attempts, the cumulative pregnancy rate can reach up to 80%.

ICSI is an effective option for couples where male factor infertility is the main concern—such as low sperm count, poor motility, or abnormal sperm morphology.

Yes, especially in cases of male infertility, because it allows for a more controlled fertilization process. However, success also depends on the quality of the egg and the resulting embryo.

The cumulative pregnancy rate after three treatment cycles can exceed 70%.

Unlike conventional ICSI, where sperm selection is done using a standard microscope, IMSI uses a high-resolution microscope (with magnification up to 6,000x) to detect even the smallest abnormalities in sperm cells.
This advanced selection helps improve embryo quality and increases implantation and pregnancy rates.

No fertility treatment can guarantee pregnancy 100%, but IMSI significantly improves success rates in couples with severe male infertility or previous IVF failures.

No. Ovarian stimulation and egg retrieval are performed under mild sedation, and embryo transfer is a painless procedure.